Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11260015rdf:typepubmed:Citationlld:pubmed
pubmed-article:11260015lifeskim:mentionsumls-concept:C1136033lld:lifeskim
pubmed-article:11260015lifeskim:mentionsumls-concept:C1517677lld:lifeskim
pubmed-article:11260015pubmed:issue3lld:pubmed
pubmed-article:11260015pubmed:dateCreated2001-3-22lld:pubmed
pubmed-article:11260015pubmed:abstractTextCutaneous mastocytosis is considered a relatively benign and indolent form of mast cell disease, which either ultimately regresses, remains stable or is only slowly progressive. Previously, it has been purported that no more than 60% of adult patients with cutaneous mastocytosis will have occult bone marrow involvement.lld:pubmed
pubmed-article:11260015pubmed:languageenglld:pubmed
pubmed-article:11260015pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11260015pubmed:citationSubsetIMlld:pubmed
pubmed-article:11260015pubmed:statusMEDLINElld:pubmed
pubmed-article:11260015pubmed:monthMarlld:pubmed
pubmed-article:11260015pubmed:issn0007-0963lld:pubmed
pubmed-article:11260015pubmed:authorpubmed-author:HenryKKlld:pubmed
pubmed-article:11260015pubmed:authorpubmed-author:CostelloCClld:pubmed
pubmed-article:11260015pubmed:authorpubmed-author:FrancisNNlld:pubmed
pubmed-article:11260015pubmed:authorpubmed-author:BunkerC BCBlld:pubmed
pubmed-article:11260015pubmed:authorpubmed-author:FearfieldL...lld:pubmed
pubmed-article:11260015pubmed:issnTypePrintlld:pubmed
pubmed-article:11260015pubmed:volume144lld:pubmed
pubmed-article:11260015pubmed:ownerNLMlld:pubmed
pubmed-article:11260015pubmed:authorsCompleteYlld:pubmed
pubmed-article:11260015pubmed:pagination561-6lld:pubmed
pubmed-article:11260015pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:meshHeadingpubmed-meshheading:11260015...lld:pubmed
pubmed-article:11260015pubmed:year2001lld:pubmed
pubmed-article:11260015pubmed:articleTitleBone marrow involvement in cutaneous mastocytosis.lld:pubmed
pubmed-article:11260015pubmed:affiliationDepartments of Dermatology and Haematology, Chelsea and Westminster Hospital, London SW10 9NH, U.K. louisefearfield@compuserve.comlld:pubmed
pubmed-article:11260015pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11260015lld:pubmed